Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade

Antibodies targeting the co-inhibitory receptor programmed cell death 1 (PDCD1, best known as PD-1) or its main ligand CD274 (best known as PD-L1) have shown some activity in patients with metastatic triple-negative breast cancer (TNBC), especially in a recent Phase III clinical trial combining PD-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilones, Karsten A., Hensler, Michal, Daviaud, Camille, Kraynak, Jeffrey, Fucikova, Jitka, Galluzzi, Lorenzo, Demaria, Sandra, Formenti, Silvia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583495/
https://www.ncbi.nlm.nih.gov/pubmed/33150045
http://dx.doi.org/10.1080/2162402X.2020.1830524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583495/
https://www.ncbi.nlm.nih.gov/pubmed/33150045
http://dx.doi.org/10.1080/2162402X.2020.1830524

Ejemplares similares